Publication: THE ANALYSIS OF THE INFLAMMATORY PROTEOME IN RHEUMATOID ARTHRITIS IDENTIFIES COMMON SIGNATURES ASSOCIATED WITH THE CLINICAL RESPONSE TO DMARDS AND TNFI THERAPIES
Loading...
Identifiers
Date
2022-06-01
Authors
Munoz-Barrera, L.
Perez-Sanchez, C.
Contreras, A. Escudero
Aguirre-Zamorano, M. A.
Gutierrez, J. Calvo
Castro, R. Ortega
Romero-Gomez, M.
Sanchez-Pareja, I.
Abalos-Aguilera, M. C.
Puerto, N. Barbarroja
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Group
Metrics
Export
Abstract
Background: The clinical outcome of the most common therapeutic options of rheumatoid arthritis (RA) patients, such as conventional disease-modifying antirheumatic drugs (DMARDs) and TNF inhibitors (TNFi) is still unpredictable, since a high percentage of patients do not response to the therapy. Innovative analyses combining high-throughput technologies and thorough clinical assessments are needed to gain insight about the management of this prevalent autoimmune disorder.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Citation
Muñoz-Barrera L, Perez-Sanchez C, Contreras AE, Aguirre-Zamorano MÁ, Gutierrez JC, Castro RO, et al. POS0440 THE ANALYSIS OF THE INFLAMMATORY PROTEOME IN RHEUMATOID ARTHRITIS IDENTIFIES COMMON SIGNATURES ASSOCIATED WITH THE CLINICAL RESPONSE TO DMARDs AND TNFI THERAPIES. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):475.1-475
Collections
SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Regional Universitario de Málaga
SAS - Hospital Universitario Virgen de la Victoria
SAS - Hospital Universitario Virgen de Valme
SAS - Hospital Universitario Virgen del Rocío
Load more Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Regional Universitario de Málaga
SAS - Hospital Universitario Virgen de la Victoria
SAS - Hospital Universitario Virgen de Valme
SAS - Hospital Universitario Virgen del Rocío